Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant α1-adrenergic antagonist therapy: results of a multicenter randomized, double-blind, placebo-controlled trial. (Q53135300)
Jump to navigation
Jump to search
scientific article published on 14 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant α1-adrenergic antagonist therapy: results of a multicenter randomized, double-blind, placebo-controlled trial. |
scientific article published on 14 February 2012 |
Statements
Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant α1-adrenergic antagonist therapy: results of a multicenter randomized, double-blind, placebo-controlled trial. (English)
Erin Brady
Evan Goldfischer
John J Kowalczyk
William R Clark
Michael Anne Shane
Nancy Dgetluck
Suzanne R Klise
14 February 2012
79
4
875-882
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference